⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MGTX News
MeiraGTx Holdings plc Ordinary Shares
Form 8-K
sec.gov
MGTX
Cone Rod Dystrophy Market Intelligence Report, 2026 Edition - Asia-Pacific Set to Become Fastest Growing Region Driven by Supportive Government Policies and Significant Investments in Biotechnology
globenewswire.com
MGTX
Form 8-K
sec.gov
MGTX
MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares
globenewswire.com
MGTX
Form 8-K
sec.gov
MGTX
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
globenewswire.com
MGTX
JNJ
Form 8-K
sec.gov
MGTX
MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia
globenewswire.com
MGTX
MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026
globenewswire.com
MGTX
Form 8-K
sec.gov
MGTX